Method for performing material synthesis, and method for absorbing co2 and producing succinic acid
By forcing the expression of specific genes in E. coli, the metabolic pathway is altered to convert CO2 into succinic acid, addressing the inefficiencies in existing methods and achieving substantial succinic acid overproduction and CO2 utilization.
Patent Information
- Application Number
- PCT/JP2023/018494
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2024-11-21
AI Technical Summary
Current methods lack an efficient and sustainable way to convert CO2 into a resource and overproduce succinic acid in microorganisms like E. coli, with co-expression of specific genes not consistently resulting in succinic acid overproduction.
Forcing the expression of genes encoding a sodium ion-dependent bicarbonate transporter and phosphoenolpyruvate carboxykinase in E. coli, altering the metabolic pathway to convert excretion to absorption, thereby increasing succinic acid production and CO2 utilization.
This method leads to significant overproduction of succinic acid and reversal of the TCA cycle direction, enhancing CO2 absorption and utilization, as demonstrated by increased mRNA expression levels and metabolic pathway simulation consistency with experimental results.
Smart Images

Figure JP2023018494_21112024_PF_FP_ABST
Abstract
Description
Methods for conducting material synthesis and methods for absorbing CO2 and producing succinic acid
[0001] The present invention relates to a method for performing material synthesis and a CO 2 and a method for producing succinic acid by absorbing the
[0002] To realize a sustainable society, for example, a carbon-negative society, 2 Reduce emissions and CO 2 There is a need for methods to turn this carbon into a resource.
[0003] A non-patent document (Scientific Reports 5:17321) describes the co-expression of the bicA gene and genes encoding sodium ion-dependent bicarbonate transporters (pck and sbtA) in Escherichia coli. When the bicA and sbtA genes were overexpressed in E. coli, excessive succinic acid production was observed, but when the bicA and pck genes were overexpressed in E. coli, excessive succinic acid production was not observed.
[0004] The present invention aims to provide a method for performing materials synthesis.
[0005] In the course of their earnest efforts to develop a method for producing succinic acid, the present inventors discovered that co-expression of large amounts of the bicA gene and the pck gene in Escherichia coli results in the overproduction of succinic acid, leading to the present invention.
[0006] In one embodiment of the present invention, a genetically modified organism is cultured to produce CO2 that has not been genetically modified. 2 The method for synthesizing a substance by forming a metabolic pathway that converts excretion into absorption is also described. The genes may be a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase, and the method may include culturing a microorganism in which each gene is forcibly expressed. The substance may be succinic acid. 2 The metabolic pathway that converts excretion to absorption may involve the following reaction in the TCA cycle: (1) succinyl-CoA + CO 2→ α-ketoglutaric acid (2) α-ketoglutaric acid + CO 2 →D-isocitric acid.
[0007] Another embodiment of the present invention is 2 The method comprises culturing a microorganism in which a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase are forcibly expressed.
[0008] A further embodiment of the present invention is a method for producing succinic acid, comprising culturing a microorganism in which the bicA and pckA genes are overexpressed.
[0009] A further embodiment of the present invention is 2 The method for inhibiting the excretion of .beta., comprises the step of culturing a microorganism in which the bicA gene and the pckA gene are overexpressed.
[0010] The bicA gene was measured at 10 6 Alternatively, the expression of the pckA gene may be at least 10 times higher than the background, or at least 10 times higher than the vector alone. The microorganism may be Escherichia coli. The bicA gene may be derived from Synechococcus, and the pckA gene may be derived from Escherichia coli.
[0011] (A) shows the nucleotide sequence of the coding region of the bicA gene in one embodiment of the present invention, and (B) the amino acid sequence of the protein it encodes. (A) shows the nucleotide sequence of the coding region of the pckA gene in one embodiment of the present invention, and (B) the amino acid sequence of the protein it encodes. (B) shows the sequences of the bicA gene and expression vector that expresses the pckA gene used in one example of the present invention. The continuous sequence is divided into three parts, (A) to (C). The sequences in (A) and (C) are derived from the pET vector, and the sequence in (B) indicates the inserted sequence. Single underlines indicate, from upstream to downstream, the optimized bicA gene and the optimized pckA gene. Dotted underlines indicate the T7 promoter, double underlines indicate the T7 terminator, and wavy underlines indicate the SD sequence. The restriction enzyme sequence used when transferring the second sequence from the pUC vector to the pET vector is shown in bold. (C) shows the results of examining the expression level of a gene inserted into an expression vector in one example of the present invention. 1 shows the results of investigating the expression levels of elements of the TCA cycle in one example of the present invention. It also shows a stoichiometric matrix calculated assuming the flux of normal rotation of the TCA cycle in one example of the present invention. It also shows the results of verifying the decomposition of each reaction in which the synthesis amount increases, which is consistent with the experimental results, in a stoichiometric matrix calculated assuming the flux of reverse rotation of the TCA cycle in one example of the present invention.
[0012] The objectives, features, advantages, and ideas of the present invention will be clear to those skilled in the art from the description in this specification, and those skilled in the art can easily reproduce the present invention from the description in this specification. The embodiments of the invention and specific examples described below show preferred embodiments of the present invention and are shown for illustrative or explanatory purposes, and do not limit the present invention thereto. It will be clear to those skilled in the art that various changes and modifications can be made based on the description in this specification within the spirit and scope of the present invention disclosed in this specification.
[0013] One embodiment of the present invention is to genetically modify and culture the modified organism to produce CO2 that has not been genetically modified. 2This is a method of synthesizing substances by forming a metabolic pathway that converts excretion sites into absorption sites.
[0014] For example, by culturing an organism in which a gene encoding a sodium ion-dependent bicarbonate transporter (ID: BICA_SYNP2) and a gene encoding phosphoenolpyruvate carboxykinase (EC 4.1.1.32) are forcibly expressed, succinic acid can be synthesized and the following reaction can occur in the TCA cycle of the organism: (1) succinyl-CoA + CO 2 → α-ketoglutaric acid (2) α-ketoglutaric acid + CO 2 →D-isocitric acid. This allows the TCA cycle reaction to run in the opposite direction to the normal direction.
[0015] A specific method may be, for example, as follows.
[0016] First, a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase are inserted into an expression vector, which is then introduced into an appropriate host for forced expression therein.
[0017] The gene encoding the sodium ion-dependent bicarbonate transporter may be, for example, the bicA gene, particularly the Synechococcus bicA gene (Ordered Locus Names: SYNPCC7002_A2371). The nucleotide sequence of the coding region of the Synechococcus bicA gene (A) and the amino acid sequence of the protein encoded by it (B) are shown in Figure 1.
[0018] The gene encoding phosphoenolpyruvate carboxykinase may be, for example, the pckA gene, particularly the E. coli pckA gene (Ordered Locus Names: J7MG59_ECOLX). The nucleotide sequence of the coding region of the E. coli pckA gene (A) and the amino acid sequence of the protein encoded thereby (B) are shown in Figure 2.
[0019] In this specification, when the above gene and protein names are used without specifying the name of the organism, they are intended to include genes and proteins derived from the above organisms as well as genes and proteins derived from other organisms.
[0020] The origin of the gene encoding the sodium ion-dependent bicarbonate transporter used is not particularly limited, but is preferably derived from Cyanobacterium, more preferably from Synechococcus. The origin of the gene encoding phosphoenolpyruvate carboxykinase used is also not particularly limited, but is preferably derived from Enterobacterales, more preferably from E. coli.
[0021] The host microorganism for forced expression is not particularly limited, but is preferably a unicellular organism, more preferably a bacterium, and most preferably Escherichia coli (E. coli).
[0022] It is a routine technique for those skilled in the art to insert a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase into an expression vector so that they can be expressed in a host, and then introduce the resulting recombinant vector into the host. In this case, as long as the inserted genes are inserted so that the sodium ion-dependent bicarbonate transporter and phosphoenolpyruvate carboxykinase function, the inserted genes do not have to be the wild-type genes themselves, but can also be partially deleted genes or genes whose codons have been optimized to enhance expression.
[0023] Here, it is preferable that the gene encoding the sodium ion-dependent bicarbonate transporter is expressed at a level 10 times or more higher than the expression level of the endogenous pckA gene when only the vector used for forced expression of the gene is introduced into the microorganism. 6It is preferable that the expression vector is expressed so that there are at least 100 copies of the gene, or at least 100 times the background level. Examples of such expression vectors include pET vectors and pUC vectors.
[0024] The medium for culturing a microorganism in which a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase have been forcibly expressed is not particularly limited, and can be easily selected by a person skilled in the art depending on the microorganism.
[0025] Using this recombinant microorganism, CO 2 For example, it is possible to absorb CO from a given liquid and produce succinic acid. 2 The recombinant microorganism can be grown, and preferably viable, in the liquid to absorb the succinic acid. Alternatively, the recombinant microorganism can be grown in a suitable medium for growth, and after incubation for a period of time, the microorganism can be harvested and the succinic acid separated by methods routine to those skilled in the art.
[0026] (1) Vector Construction: An expression vector was designed in which the bicA gene derived from the cyanobacterium Synechocystis PCC6803 and the pck gene derived from Escherichia coli BL21(DE3) were placed between the T7 promoter and T7 terminator in a null pET vector. Specifically, the full-length plasmid was chemically synthesized by inserting the sequence shown in Figure 3(B) into a pUC vector, and the sequence shown in Figure 3(B) was inserted into the pET vector using the restriction enzymes shown in bold in Figure 3. The bicA gene and pck gene sequences were optimized to increase expression. (2) Forced Expression: The expression vector constructed in (1) was transfected into Escherichia coli BL21(DE3) cells, which were then plated onto an LB plate containing 100 μg / mL ampicillin and transformed by overnight incubation in a 37°C incubator.
[0027] The resulting transformants were inoculated into 50 mL of LB + ampicillin medium, grown overnight (usually for 16 hours or more), and then harvested. mRNA was extracted using RNAprotect Bacteria Reagent (Qiagen) and purified using RNeasy Mini Kits (Qiagen). The resulting mRNA was reverse transcribed using Random Hexamers and SuperScript III RT (200 U / ul).
[0028] The expression level of the obtained cDNA was examined by real-time PCR. Using Premix Ex Taq (Perfect Real Time) (Takara Bio Inc.) and the primers and probes with the following sequences, amplification and melting curve analysis were performed using a QuantStudio 12 K Flex Real-Time PCR System (Thermo Fisher Scientific, US) to calculate the expression level. The amplification conditions were denaturation at 95°C for 30 seconds, followed by 40 cycles of 95°C for 3 seconds and 60°C for 30 seconds. The results are shown in Figure 4. As negative controls, the same procedure was performed without adding DNA (NC), and a control transformed with only the null pET vector without an insert sequence (WT) was used. bicA gene: Fw: TTTTTTTTGCGGCCCTCTTC (SEQ ID NO: 1) Rev: GGGCCGGTCGGTTCAC (SEQ ID NO: 2) Probe: ACCCCGACGCTGAT (SEQ ID NO: 3) pckA gene: Fw: GCCGATCAAACCCAGTATCACT (SEQ ID NO: 4) Rev: TCAGTACCGGCCAGTTTGG (SEQ ID NO: 5) Probe: CCTCTCTGGCTTCAC (SEQ ID NO: 6) As a result, for the bicA gene, about 10 6 The number of mRNA molecules expressed was approximately 8 x 10 for the pckA gene. 5 The number of mRNA molecules expressed was 10 for the bicA gene. 4 The pckA gene was more than 10 times higher than the vector alone.2 The vector-introduced strain (referred to as WT) and the recombinant gene-introduced strain (referred to as ENG or No. 5) were cultured in SOC medium (supplemented with 100 mg / mL Amp) at 37°C. After about 20 hours, the OD 600 When the OD reached 0.5, 1 mM IPTG was added and the culture was continued. 600 Dilute to 0.9, 12 CO 2 (1 atm) or 13 CO 2 The mixture was cultured overnight in a desiccator under a pressure of 1 atm. 600 teeth, 12 CO 2 (1 atm) for WT and ENG, the values were 0.7 and 1.32, respectively. 13 CO 2 The WT cultured under (1 atm) had a pH of 1.23, and the ENG cultured under (1 atm) had a pH of 0.75.
[0029] Centrifuge to collect the bacterial cells, and then measure the OD 600 The pH was adjusted to 1.0. After freezing 10 mL of the solution, it was diluted to 6.4 mM NH 4 HCO 3 The samples were suspended in an aqueous solution and then sonicated. After centrifugation, the supernatant was subjected to ultrafiltration (using a 3 kDa filter), and 20 μL of the filtrate was analyzed by LC / MS. LC (liquid chromatography) and MS (mass spectrometry) were performed under the following conditions: LC instrument: UltiMate 3000 (ThermoFisher); column: Hypercarb 4.6 × 150 mm (ThermoFisher, PN 35003-154630, lot 3-916, SN 20130692); developing solvent: A: 6.4 mM NH 4 HCO 3, B: methanol, 0.3 mL / min, 0-99% Bover 10 min, equilibration 20 min. MS Instrument: Orbitrap Q ExactiveFocus m / z range: 56.7-850.0 Ion mode: switching (negative / positive) Resolution: 70,000 The internal standards used were L-methionine sulfone and PIPES (both obtained from Fujifilm Wako Co., Ltd.), compounds not present as metabolites in native E. coli. A 10 mM aqueous solution of each of these internal standards was prepared and stored at 4°C, and spiked into the labeled E. coli extract.
[0030] Furthermore, standard substances were prepared for metabolites involved in the TCA cycle (oxaloacetic acid, monopotassium phosphoenolpyruvate, sodium pyruvate, L(-)-malic acid, glycine, L-serine, acetyl-Coenzyme A sodium salt, and acetic acid), and the amounts of each metabolite were measured. The results are shown in Figure 5.
[0031] As shown in Figure 5, for three compounds, L(-)-malic acid, succinic acid, and fumaric acid / maleic acid (hereinafter referred to as FA / MA) (RT 9-10 minutes), a mass increase of approximately 0.4 was observed in the WT strain and approximately 0.6-0.9 in the No. 5 strain. For aspartic acid, citric acid + isocitric acid, and FA / MA (RT 7-8 minutes), a more significant mass increase was observed than for L-methionine sulfone, pyruvic acid, phosphoenolpyruvate monopotassium salt, serine, and acetic acid. For glycine, a similar mass increase was observed in both the WT strain and the No. 5 strain. Thus, in the absence of glucose, 13 C-labeled CO 2 In the presence of E. coli CO 2 Increased uptake of L(-)-malic acid, succinic acid, monopotassium phosphoenolpyruvate, and pyruvate 13 The proportion of C increases. (4) CO 2 Fixation location The rotation direction of the TCA cycle and the CO2 fixation location were simulated based on the experimental results and structural sensitivity analysis described in (3).
[0032] Structural sensitivity analysis is a technique that suggests enzymes that affect the amount of substances in a metabolic network based on the structure of the metabolic network (A. Mochizuki and B. Fiedler, J. Theor. Biol. 367, 189(2015)). Using this method, we constructed a stoichiometry matrix from the chemical reaction network of the central metabolic pathway of Escherichia coli (T. Okada and A. Mochizuki, Phys. Rev. Lett. 117, 048101(2016)). We interpreted the simulation results based on the experimental results described in (3).
[0033] First, the chemical reaction network of the central metabolic system of E. coli is 2 The stoichiometric matrices were calculated for each of the normal (Fig. 6) and reverse (Fig. 7) rotational fluxes of the TCA cycle (shown in the bottom right of Fig. 6 and Fig. 7, respectively). The results were compared with those described in (3), and the results showed no agreement with those for normal rotation, indicating that the TCA cycle was functioning in reverse rotation under the experimental conditions.
[0034] The stoichiometric matrix above was analyzed by decomposing each reaction that showed consistent results with the experimental results of (3) and increased synthesis (Figure 7, r1-r22). As a result, in the matrix that promoted r20 and increased synthesis of L(-)-malic acid, succinic acid, and monopotassium phosphoenolpyruvate, CO2 uptake was promoted in r7 (succinyl-CoA + CO2 → α-ketoglutaric acid), r6 (α-ketoglutaric acid + CO2 → D-isocitric acid), and r11 (monopotassium phosphoenolpyruvate + CO2 → oxaloacetate). Thus, forced overexpression of the above genes results in the following reactions in the TCA cycle: (1) succinyl-CoA + CO2 → α-ketoglutaric acid; (2) α-ketoglutaric acid + CO2 → D-isocitric acid.
[0035] The present invention makes it possible to provide a method for carrying out novel substance synthesis.
Claims
1. By modifying one or more genes and culturing the modified organism, it is possible to obtain CO that has not been genetically modified. 2 A method of synthesizing substances by forming a metabolic pathway that converts excretion sites into absorption sites.
2. The method according to claim 1, wherein the genes are a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase, the method comprising a step of culturing a microorganism in which each of the genes is forcibly expressed, and the substance is succinic acid.
3. The above CO 2 The method according to claim 1, wherein the metabolic pathway in which the excretion site is converted to absorption causes the following reaction in the TCA cycle: (1) succinyl CoA + CO 2 → α-ketoglutaric acid (2) α-ketoglutaric acid + CO 2 →D-isocitric acid.
4. CO 2 A method for absorbing an organism comprising: culturing a microorganism in which a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase are forcibly expressed.
5. A method for synthesizing succinic acid by culturing an organism in which a gene encoding a sodium ion-dependent bicarbonate transporter and a gene encoding phosphoenolpyruvate carboxykinase are forcibly expressed, and causing the following reaction in the TCA cycle of the organism: (1) succinyl CoA + CO 2 → α-ketoglutaric acid (2) α-ketoglutaric acid + CO 2 →D-isocitric acid.
6. The gene encoding the sodium ion-dependent bicarbonate transporter was 10 6 6. The method of claim 5, wherein the gene encoding phosphoenolpyruvate carboxykinase is expressed at least 10-fold over background, or at least 100-fold over the vector alone, and the gene encoding phosphoenolpyruvate carboxykinase is expressed at least 10-fold over the vector alone.
7. The method of claim 5 or 6, wherein the organism is Escherichia coli.
8. The method according to any one of claims 5 to 7, wherein the gene encoding the sodium ion-dependent bicarbonate transporter is derived from Synechococcus and the gene encoding phosphoenolpyruvate carboxykinase is derived from Escherichia coli.
Citation Information
Patent Citations
Genetically engineered microorganisms and methods for improving aldehyde dehydrogenase activity
JP2022530475A
Fermentation process for the production of organic acids
US20130130339A1
Bioprocess, method for cultivating microbes, method for producing target substance, and bioprocess device
WO2023068295A1
